International Journal of Cancer Management
The Official Journal of Cancer Research Center (CRC), Shahid Beheshti University of Medical Sciences
OpenCitations
Works that cite this article, indexed by OpenCitations.
Case Report: Dual resistance to dasatinib/olverembatinib in accelerated-phase cml: identification of a novel SPECC1L-inserted e8a2 BCR::ABL1 transcript and ABL1 V379I mutation
Frontiers in Oncology 15 (2025)
Jingjing Fu; Yangming Tang; Xueqin Ruan; Runfa Wang; Tong Chen; Li Jiang; Yanli He; Zhihong Xu; Balian Wang; Haiqin Zhang; Jing Zhou; Mei Lan; Hongrui Li
ABL Kinase Domain Mutations in Iranian Chronic Myeloid Leukemia Patients with Resistance to Tyrosine Kinase Inhibitors
Laboratory Medicine 52(2) (2020)
Mahboobeh Shojaei; Hamid Rezvani; Azita Azarkeivan; Behzad Poopak
BCR-ABL Kinase Domain mutations - E255K, Y253 H and M351T among Sudanese population with CML
Pharmacophore 12(4) (2021)
Hala Elsir Khair; Abozer Yousif Elderdery; Bakri Yousef Nour; Hadeil Mohamed Elamin Idris; Gamila Ali Attaelmanan; Babker Ahmed Mohamed; Hisham Ali Waggiallah
Utility of T315I mutation in Egyptian patients with chronic myeloid leukemia
Egyptian Journal of Basic and Applied Sciences 11(1) (2024)
Alyaa Mohamed Ghoneem; Eman A. Soliman; Shaimaa El-Ashwah; Mohammed El Agdar; Hasan Abdel-Ghaffar
Mutation Analysis of ABL1 Gene and its Relation to the Achievement of Major Molecular Response in Indonesian Chronic Myeloid Leukemia Patients
Current Pharmacogenomics and Personalized Medicine 17(1) (2020)
Reni Widyastuti; Melva Louisa; Ikhwan Rinaldi; Riki Nova; Instiaty Instiaty; Rizky Priambodo
Occurrence of Existing BCR-ABL Baseline Mutations and Associated Haplotype (NmR) Among CML Patients with Diverse IM Response: A Hospital-based Study from North-East India
Biochemical Genetics 62(6) (2024)
Gautam Hazarika; Manash Jyoti Kalita; Partha Pratim Das; Simanta Kalita; Kalpajit Dutta; Lipika Lahkar; Anjanjyoti Rajkonwar; Mohammed Ghaznavi Idris; Vinotsale Khamo; Giriraj Kusre; Subhash Medhi
Effects of Two Common Promoter Polymorphisms of Transforming Growth Factor-β1 on Breast Cancer Risks in Ahvaz, West South of Iran
Iranian Journal of Cancer Prevention InPress(InPress) (2016)
Somayeh Parvizi; Ghorban Mohammadzadeh; Maryam Karimi; Mozhgan Noorbehbahani; Alireza Jafary
New Developments in Chronic Myeloid Leukemia: Implications for Therapy
Iranian Journal of Cancer Prevention InPress(InPress) (2016)
Sanaz Tabarestani; Abolfazl Movafagh
Novel ABL1 mutation in a Moroccan CML patient with Imatinib resistance
Cancer Genetics 288-289 (2024)
Ihssane El Bouchikhi; Hajar Azami Idrissi; Ahmed Lazraq; Badreddine El Makhzen; Mohamed Ahakoud; Rhizlane Berrady; Karim Ouldim; Laila Bouguenouch; Mohammed El-Azami-El-Idrissi
Imatinib Efficacy, Safety and Resistance in Iranian Patients with Chronic Myeloid Leukemia: A Review of Literature
International Journal of Hematology-Oncology and Stem Cell Research (2021)
Asiyeh Amouei; Nesa Daeian; Seyedeh Sana Khezrnia; Ava Mansouri; Molouk Hadjibabaie
Induction of K562 Cell Apoptosis by As4S4 via Down-Regulating miR181
Medical Science Monitor 23 (2017)
Jiangjiang Gong; Shunli Zheng; Lei Zhang; Yi Wang; Jiali Meng
Differences in Variants in the Structural Domain of <b><i>BCR-ABL1</i></b> Kinase between Chinese Han and Minority Patients with Chronic Myeloid Leukemia by Sanger Sequencing and Next-Generation Sequencing
Cytogenetic and Genome Research 162(4) (2022)
Dilinazi Abulaiti; Niluopaer Tuerxun; Huan Wang; Patiguli Abulizi; Fang Zhao; Yang Liu; Jianping Hao